cholic acid has been researched along with Carcinoma, Hepatocellular in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DH; Kwak, K; Larson, AC; Mouli, SK; Yu, B | 1 |
| Chun, HJ; Kwon, YH; Shim, YJ | 1 |
| Cai, K; Fan, X; Gao, A; Han, F; Hao, Y; Jiang, J; Liu, Q; Liu, W; Shen, Q; Shi, Y; Wang, Z; Yang, C; Yu, J | 1 |
| Cheng, R; Gong, T; Huang, Y; Li, D; Liang, W; Song, Z; Su, D; Wen, C; Yu, B; Zhao, X | 1 |
| Deuschle, U; Fujimoto, M; Hijikata, T; Nishida, T; Taira, S; Takahashi, T; Tsuneyama, K | 1 |
| Jiang, G; Yu, C; Zhang, J | 1 |
| Apte, U; Beggs, K; Bhushan, B; Borude, P; Edwards, G; Gunewardena, S; Li, H; Manley, MW; O'Neil, M; Roy, N; Sun, L; Walesky, C | 1 |
| Baller, JF; Faber, KN; Geuken, M; Heegsma, J; Hoeke, MO; Jansen, PL; Kuipers, F; Moshage, H; Plass, JR; van Rijsbergen, D | 1 |
| Daitoku, H; Fujii, H; Fukamizu, A; Hirota, K; Ishida, J; Kato, H; Matsuoka, T; Nangaku, M; Saito, T; Shimamoto, Y; Takeda, J; Yamagata, K | 1 |
| Arnoldi, A; Castiglioni, S; D'Agostina, A; Duranti, M; Lovati, MR; Magni, C; Manzoni, C; Morandi, S; Sirtori, CR | 1 |
| Cooper, AD; Craig, WY; Everson, GT; Taniguchi, T | 1 |
| Kato, Y; Khan, KN; Nagataki, S; Nakao, K; Nakata, K; Tsutsumi, T | 1 |
| Axelson, M; Everson, GT; Mörk, B | 1 |
| Everson, GT; Polokoff, MA | 1 |
14 other study(ies) available for cholic acid and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Sodium Cholate Bile Acid-Stabilized Ferumoxytol-Doxorubicin-Lipiodol Emulsion for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemoembolization, Therapeutic; Contrast Media; Doxorubicin; Drug Liberation; Drug Stability; Emulsions; Ethiodized Oil; Ferrosoferric Oxide; Infusions, Intra-Arterial; Kinetics; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Multimodal Imaging; Rats, Sprague-Dawley; Sodium Cholate; Tomography, X-Ray Computed | 2020 |
Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet.
Topics: Amino Acids; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cholesterol; Cholesterol, Dietary; Cholic Acid; Diet, High-Fat; Dietary Supplements; Diethylnitrosamine; Disease Progression; Gene Expression Regulation; Lipid Metabolism; Liver; Male; Metabolic Networks and Pathways; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Transcriptome | 2022 |
Synthesis and biological evaluation of cholic acid-conjugated oxaliplatin as a new prodrug for liver cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cholic Acid; Humans; Liver Neoplasms; Mice; Mice, Inbred C57BL; Oxaliplatin; Prodrugs; Rats; Rats, Sprague-Dawley | 2023 |
β-Cyclodextrin-cholic acid-hyaluronic acid polymer coated Fe
Topics: Antineoplastic Agents; beta-Cyclodextrins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cholic Acid; Doxorubicin; Graphite; Humans; Hyaluronic Acid; Hyperthermia, Induced; Liver Neoplasms; Pharmaceutical Preparations; Phototherapy; Polymers | 2021 |
Tsumura-Suzuki obese diabetic mice-derived hepatic tumors closely resemble human hepatocellular carcinomas in metabolism-related genes expression and bile acid accumulation.
Topics: Acyltransferases; Aldehyde Reductase; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; Betaine-Aldehyde Dehydrogenase; Carcinoma, Hepatocellular; Cholic Acid; Diabetes Mellitus, Experimental; Disease Models, Animal; Down-Regulation; Gene Expression; Glutamate-Ammonia Ligase; Humans; Liver Neoplasms; Male; Mice; Mice, Obese; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Taurocholic Acid | 2018 |
Synthesis of cholic-acid-carrying polymer and in-vitro evaluation of hepatoma-targeting nanoparticles decorated with the polymer.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Chemistry Techniques, Synthetic; Cholic Acid; Cholic Acids; Drug Carriers; Endocytosis; Humans; Liver Neoplasms; Nanoparticles; Polymers; Polyvinyls | 2016 |
Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Topics: Adult; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Cholic Acid; Diethylnitrosamine; Endoplasmic Reticulum Stress; Female; Gene Expression Regulation, Neoplastic; Hepatocytes; Humans; Inflammation Mediators; Kruppel-Like Factor 4; Liver Neoplasms, Experimental; Male; Mice, Inbred C57BL; Middle Aged; Mitogen-Activated Protein Kinases; Neoplastic Stem Cells; NF-kappa B; Signal Transduction; Tumor Burden; Young Adult | 2016 |
Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
Topics: Alitretinoin; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Carcinoma, Hepatocellular; Cell Line, Tumor; Chenodeoxycholic Acid; Cholic Acid; DNA-Binding Proteins; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; Organic Anion Transporters, Sodium-Dependent; Receptors, Cytoplasmic and Nuclear; Response Elements; Retinoid X Receptor alpha; Symporters; Transcription Factors; Tretinoin; Vitamin A; Vitamin A Deficiency | 2009 |
Inhibitory effect of the small heterodimer partner on hepatocyte nuclear factor-4 mediates bile acid-induced repression of the human angiotensinogen gene.
Topics: Angiotensinogen; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Bile Acids and Salts; Binding Sites; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Cholic Acid; DNA; DNA-Binding Proteins; Female; Gene Expression; Gene Expression Regulation; HeLa Cells; Hepatocyte Nuclear Factor 4; Humans; Liver; Luciferases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutagenesis; Phosphoproteins; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Recombinant Proteins; RNA, Messenger; Transcription Factors; Transfection; Tumor Cells, Cultured | 2004 |
Proteins of white lupin seed, a naturally isoflavone-poor legume, reduce cholesterolemia in rats and increase LDL receptor activity in HepG2 cells.
Topics: Animals; Anticholesteremic Agents; Carcinoma, Hepatocellular; Caseins; Cholesterol; Cholesterol, Dietary; Cholic Acid; Hypercholesterolemia; Isoflavones; Liver; Liver Neoplasms; Lupinus; Male; Plant Extracts; Plant Proteins; Rats; Rats, Sprague-Dawley; Receptors, LDL; Seeds; Tumor Cells, Cultured | 2004 |
Characteristics and regulation of bile salt synthesis and secretion by human hepatoma HepG2 cells.
Topics: Bile Acids and Salts; Biological Transport; Blotting, Northern; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholic Acid; Cholic Acids; Gas Chromatography-Mass Spectrometry; Humans; Hydroxycholesterols; Liver Neoplasms; Microsomes, Liver; Progesterone; RNA, Messenger; Tumor Cells, Cultured | 1994 |
Regulation of alkaline phosphatase gene expression in human hepatoma cells by bile acids.
Topics: Alkaline Phosphatase; Bile Acids and Salts; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Cholic Acid; Dose-Response Relationship, Drug; Gene Expression; Humans; Liver Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Ursodeoxycholic Acid | 1998 |
Bile acid synthesis in cultured human hepatoblastoma cells.
Topics: Bile Acids and Salts; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Cholesterol; Cholic Acid; Cholic Acids; Chromatography, Gas; Gas Chromatography-Mass Spectrometry; Humans; Liver Neoplasms; Mass Spectrometry; Methylation; Steroids; Tumor Cells, Cultured | 1991 |
HepG2. A human hepatoblastoma cell line exhibiting defects in bile acid synthesis and conjugation.
Topics: Bile Acids and Salts; Carcinoma, Hepatocellular; Cell Line; Chenodeoxycholic Acid; Cholestanols; Cholic Acid; Cholic Acids; Gas Chromatography-Mass Spectrometry; Humans; Liver Neoplasms | 1986 |